The Form 144 signals intent to sell, but the dollar amount is small relative to market cap and may be routine portfolio diversification. Monitor for actual Form 4 filings to confirm execution; the prior August 3 sale was executed, suggesting this one may also proceed. No immediate bearish read-through given the small size and strong analyst consensus.
Price Chart
Executive Summary
Patrick Burnett, an officer of Arcutis Biotherapeutics, filed a Form 144 on August 11, 2026, indicating intent to sell 15,000 shares of common stock with an approximate market value of $397,824. This is a relatively small sale relative to the company's $3.3B market cap, but it follows a recent insider sale on August 3, 2026, and comes amid a period of strong analyst bullishness (86% buy ratings) and a 60% historical win rate on prior ARQT reports.
Key Facts
- Officer Patrick Burnett filed Form 144 to sell 15,000 shares of ARQT common stock.
- Approximate market value of the proposed sale is $397,824.
- The shares were acquired via stock option exercise on January 12, 2024.
- A prior insider sale of 955 shares occurred on August 3, 2026, for $24,941.54.
- ARQT has a market cap of $3.3B and 86% of analysts rate it a Buy or Strong Buy.
Financial Impact
Proposed sale of 15,000 shares valued at ~$398K, representing ~0.01% of market cap.
Risk Factors
- Insider selling could accelerate if additional officers follow suit.
- The stock has shown high volatility historically, with several prior neutral reports seeing large swings.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001628280-26-055797 |
| Document: 0001628280-26-055797-index.html | 0001628280-26-055797 |
| Document: 0001628280-26-055797.txt | 0001628280-26-055797 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 24, 2026 5w ago | Insider Cluster | $24.86 $26.38 | ▲ +6.11% | ▲ +5.87% | $25.16 (+1.21%) |
Aug 21, 2026 6w ago | Insider Cluster | $25.08 $25.96 | ▲ +3.51% | ▲ +4.04% | $25.16 (+0.32%) |
Aug 19, 2026 6w ago | Insider Cluster | $25.35 $25.38 | ▲ +0.12% | ▲ +0.12% | $25.16 (−0.75%) |
Aug 11, 2026 7w ago | 144 | $26.28 $23.38 | ▼ −11.04% | ▼ −9.14% | $25.16 (−4.26%) |
Aug 6, 2026 8w ago | Insider Cluster | $26.43 $23.66 | ▼ −10.48% | ▼ −11.08% | $25.16 (−4.81%) |
Aug 5, 2026 8w ago | Press Release | $26.43 $23.66 | ▼ −10.48% | ▼ −11.08% | $25.16 (−4.81%) |
Aug 3, 2026 8w ago | 144 | $26.03 $23.75 | ▼ −8.76% | ▼ −7.52% | $25.16 (−3.34%) |
Jun 29, 2026 13w ago | Press Release | $26.22 $27.84 | ▲ +6.18% | ▲ +7.21% | $25.16 (−4.04%) |
Jun 18, 2026 15w ago | Insider Cluster | $26.21 $27.74 | ▲ +5.84% | ▲ +5.30% | $25.16 (−4.01%) |
Jun 9, 2026 16w ago | 8-K | $23.23 $28.78 | ▲ +23.89% | ▲ +20.27% | $25.16 (+8.31%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access